| Medical and Health Sciences | 2021-2025 | 83 | GB 8 | 99.98 |
| Obstetrics and Gynecology | Lifetime | 21 | GB 8 | 99.82 |
| Pediatrics, Perinatology and Child Health | Lifetime | 67 | GB 18 | 99.77 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 2 | GB 1 | 99.98 |
| Obstetrics and Gynecology | 2021-2025 | 1 | GB 1 | 99.96 |
| Epidemiology | 2021-2025 | 132 | GB 12 | 99.16 |
| Public, Environmental and Occupational Health | 2021-2025 | 282 | GB 20 | 97.59 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 782 | GB 50 | 84.96 |
| Assisted Reproductive Technology and Twin Pregnancy | Lifetime | 14 | GB 3 | 99.74 |
| COVID-19 Impact on Reproduction | Lifetime | 7 | GB 1 | 99.63 |
| Pregnancy and preeclampsia studies | Lifetime | 37 | GB 16 | 99.70 |
| Maternal and fetal healthcare | Lifetime | 19 | GB 6 | 99.74 |
| Prenatal Screening and Diagnostics | Lifetime | 34 | GB 12 | 99.60 |
| Birth, Development, and Health | Lifetime | 129 | GB 36 | 99.43 |
| COVID-19 and healthcare impacts | Lifetime | 71 | GB 16 | 98.35 |
| Ectopic Pregnancy Diagnosis and Management | Lifetime | 24 | GB 6 | 99.56 |
| Cardiovascular Issues in Pregnancy | Lifetime | 63 | GB 6 | 99.19 |
| Gestational Diabetes Research and Management | Lifetime | 159 | GB 30 | 98.82 |
| Fetal and Pediatric Neurological Disorders | Lifetime | 142 | GB 18 | 98.39 |
| Pregnancy and Medication Impact | Lifetime | 154 | GB 20 | 97.92 |
| Maternal and Perinatal Health Interventions | Lifetime | 221 | GB 34 | 98.44 |
| Neonatal and fetal brain pathology | Lifetime | 431 | GB 37 | 97.48 |
| Cardiovascular Health and Disease Prevention | Lifetime | 639 | GB 54 | 97.25 |
| Parvovirus B19 Infection Studies | Lifetime | 289 | GB 22 | 96.85 |
| Preterm Birth and Chorioamnionitis | Lifetime | 303 | GB 27 | 95.93 |
| Pregnancy and preeclampsia studies | 2021-2025 | 1 | GB 1 | 99.93 |
| COVID-19 Impact on Reproduction | 2021-2025 | 1 | GB 1 | 99.85 |
| Assisted Reproductive Technology and Twin Pregnancy | 2021-2025 | 1 | GB 1 | 99.95 |
| Maternal and fetal healthcare | 2021-2025 | 1 | GB 1 | 99.83 |
| Prenatal Screening and Diagnostics | 2021-2025 | 1 | GB 1 | 99.92 |
| Parvovirus B19 Infection Studies | 2021-2025 | 2 | GB 1 | 98.76 |
| Birth, Development, and Health | 2021-2025 | 30 | GB 5 | 98.99 |
| Ectopic Pregnancy Diagnosis and Management | 2021-2025 | 6 | GB 3 | 98.73 |
| Fetal and Pediatric Neurological Disorders | 2021-2025 | 13 | GB 4 | 98.14 |
| Herpesvirus Infections and Treatments | 2021-2025 | 23 | GB 3 | 97.76 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 29 | GB 1 | 97.24 |
| Preterm Birth and Chorioamnionitis | 2021-2025 | 11 | GB 2 | 97.98 |
| Pregnancy and Medication Impact | 2021-2025 | 26 | GB 3 | 97.28 |
| COVID-19 and healthcare impacts | 2021-2025 | 156 | GB 38 | 96.66 |
| Global Maternal and Child Health | 2021-2025 | 181 | GB 17 | 97.43 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 65 | GB 7 | 96.32 |
| Maternal and Perinatal Health Interventions | 2021-2025 | 130 | GB 17 | 96.69 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 307 | GB 36 | 95.70 |
| Gestational Diabetes Research and Management | 2021-2025 | 179 | GB 21 | 94.94 |
| Reproductive System and Pregnancy | 2021-2025 | 190 | GB 15 | 94.50 |
| Neonatal and fetal brain pathology | 2021-2025 | 147 | GB 18 | 95.26 |
| Poxvirus research and outbreaks | 2021-2025 | 98 | GB 4 | 92.73 |
| Bacterial Infections and Vaccines | 2021-2025 | 157 | GB 28 | 90.59 |
| Bacillus and Francisella bacterial research | 2021-2025 | 144 | GB 9 | 88.08 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 335 | GB 34 | 85.58 |
| Pregnancy-related medical research | 2021-2025 | 221 | GB 25 | 85.82 |
| Congenital Diaphragmatic Hernia Studies | 2021-2025 | 886 | GB 52 | 78.80 |
| Blood groups and transfusion | 2021-2025 | 784 | GB 42 | 75.79 |
| Congenital Anomalies and Fetal Surgery | 2021-2025 | 621 | GB 38 | 74.36 |
